Evidence map›Paper›PMID 32131843›Full record

ArticleRespiratory research2020

Adaptive NKG2C+ natural killer cells are related to exacerbations and nutritional abnormalities in COPD patients.

Sergi Pascual-Guardia, Michelle Ataya, Isabel Ramírez-Martínez, José Yélamos, Roberto Chalela, Salomé Bellido, Miguel López-Botet, Joaquim Gea

Open access · goldAbstract read
In one paragraph

Article in Respiratory research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Sergi Pascual-GuardiaRespiratory Department, Hospital del Mar, Pg. Marítim 27, 08003, Barcelona, Spain. spascual@parcdesalutmar.cat.ORCID http://orcid.org/0000-0002-6567-0916
Michelle AtayaHospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
Isabel Ramírez-MartínezImmunology Department, Hospital del Mar, Barcelona, Spain.
José YélamosHospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
Roberto ChalelaRespiratory Department, Hospital del Mar, Pg. Marítim 27, 08003, Barcelona, Spain.
Salomé BellidoRespiratory Department, Hospital del Mar, Pg. Marítim 27, 08003, Barcelona, Spain.
Miguel López-BotetHospital del Mar Medical Research Institute (IMIM), Barcelona, Spain.
Joaquim GeaRespiratory Department, Hospital del Mar, Pg. Marítim 27, 08003, Barcelona, Spain.
Universitat Pompeu Fabra · ESHospital Del Mar · ESHospital del Mar Research Institute · ES

Funding

Conselleria d'Educació, Investigació, Cultura i Esport (ES) SAF2013-49063-C2-1-RMINECO Plan Estatal I+D Retos SAF2014-54371MINECO Plan Estatal I+D Retos SAF2016-80363-C2-1-RSociedad Española de Neumología y Cirugía Torácica 2015
6 · The paper itself

Abstract

Chronic obstructive pulmonary disease (COPD) is a chronic and often progressive disorder with a heterogeneous presentation and frequent systemic manifestations. Several aspects like persistence in smoking habit, continuous exacerbations, alpha-1-antitrypsin deficiency and inflammatory-immune response, are involved in the pathophysiology and progression of the disease. However, the role of natural killer (NK) cells remains controversial. Otherwise, human cytomegalovirus (HCMV) infection has been reported to induce an adaptive differentiation and expansion of an NK cell subset which carries the CD94/NKG2C receptor, which may contribute to an upset immune defense. For these reasons, our objective is to assess the distribution of NK cells and their subset in COPD patients and some of its phenotypes.

methodsPeripheral blood samples were obtained from 66 COPD patients. HCMV serology and the proportions of total NK cells and the NKG2C+ and NKG2A+ subsets were evaluated by flow cytometry. The NKG2C genotype was also assessed.

resultsEighty-eight per cent of COPD patients were HCMV(+), and the proportions of total NK cells were higher in patients with severe-very severe airway obstruction than in those with only mild-moderate involvement. There were no differences in the proportions of NKG2C+ cells between controls and COPD, either among COPD patients classified by severity of the disease. However, the percentage of NKG2C+ cells were higher in COPD patients with frequent exacerbations than in occasional exacerbators, and higher in cases with reduced lean mass (Fat free mass index) than in those with normal nutritional status.

conclusionThese results suggest a relationship between levels of NKG2C+ cells in COPD patients and clinical variables closely linked to a poor/worse prognosis.

Indexed as

AgedBiomarkersFemaleForced Expiratory VolumeHumansKiller Cells, NaturalMaleMiddle AgedNK Cell Lectin-Like Receptor Subfamily CNutritional StatusPilot ProjectsPulmonary Disease, Chronic ObstructiveBiomarkersNK Cell Lectin-Like Receptor Subfamily CChronic obstructive pulmonary diseaseExacerbationFat free mas indexHuman CytomegalovirusNK cellsNKG2CNutritional status

Identifiers

PMID32131843
PMCPMC7057582
OpenAlexW3009441360

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.